 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Courtagen Planning 510(k), CE Mark Submissions for Q400 Device, Eyeing $15M-Plus Funding Round
May 11, 2012
Courtagen Planning 510(k), CE Mark Submissions for Q400 Device, Eyeing $15M-Plus Funding Round
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sandia Looks to Out-License New Point-of-Care Multiplex Immunoassay Platform
July 20, 2012 / ProteoMonitor - Pronota Validates Pre-Eclampsia Markers; Plans Clinical Study to Support 510(k) Submission
July 13, 2012 / ProteoMonitor - Scienion Places Arrayers with Procognia, Courtagen for Chip Production
July 3, 2012 / BioArray News - Courtagen's Mitochondrial DNA Sequencing Projects Could Lead to New Protein Array Tests
June 19, 2012 / BioArray News - ASU's Biodesign Institute Wins $30M DoD Contract for Immunosignature-Based Pathogen Detection Chip
April 27, 2012 / ProteoMonitor